GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » C&R Research Inc (XKRX:359090) » Definitions » Capital Expenditure

C&R Research (XKRX:359090) Capital Expenditure : ₩-685.79 Mil (TTM As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is C&R Research Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

C&R Research's cash flow for capital expenditures for the three months ended in Mar. 2025 was ₩-61 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2025 was ₩-685.79 Mil.

C&R Research Capital Expenditure Historical Data

The historical data trend for C&R Research's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

C&R Research Capital Expenditure Chart

C&R Research Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Capital Expenditure
-544.51 -1,281.06 -1,258.03 -218.94 -809.02

C&R Research Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -184.27 -408.70 -63.09 -152.96 -61.05

C&R Research Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-685.79 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

C&R Research Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » C&R Research Inc (XKRX:359090) » Definitions » Capital Expenditure
Comparable Companies
XKRX:263700 XKRX:032850 XKRX:390110 XKRX:226330 XKRX:099750 XKRX:315640 XKRX:071200 XKRX:032620 XKRX:338220 VEEV GEHC ASX:PME TEM DOCS TSE:2413 HQY WAY BTSG HKSE:02587 HNGE
Traded in Other Exchanges
N/A
Address
412 Yeoksam-ro, C&R Building, Gangnam-gu, Seoul, KOR
Website
http://www.cnrres.com
C&R Research Inc provides a quotation on clinical trial service.

C&R Research Headlines

No Headlines